Related Experiment Video
Updated: Jun 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Repeat adverse events long after percutaneous coronary revascularization in diabetics
E Cavallero1, G Biondi-Zoccai, A Mazzanti
1Division of Cardiology, University of Turin, Turin, Italy.
Insights
Diabetics with coronary artery disease frequently experience recurrent adverse cardiac events after percutaneous coronary intervention (PCI). Repeat PCI is often a safe and successful management strategy for these patients.
Area of Science:
- Cardiology
- Diabetology
- Interventional Cardiology
Background:
- Diabetics with coronary artery disease (CAD) have a high risk of adverse events post-coronary revascularization.
- Recurrence rates after initial revascularization in diabetic patients remain under-evaluated.
Purpose of the Study:
- To assess the long-term rates of recurrent adverse events in diabetic patients undergoing percutaneous coronary intervention (PCI).
- To evaluate the safety and efficacy of repeat PCI in managing recurrent events in this population.
Main Methods:
- Retrospective analysis of 429 type-2 diabetic patients treated with PCI between July 2002 and December 2005.
- Data collection included baseline characteristics and long-term outcomes.
- Key endpoints: major adverse cardiac events (MACE), repeat target vessel revascularization (TVR-PCI), non-TVR PCI, and stent thrombosis.
Main Results:
- A total of 429 diabetic patients were included; 54% received drug-eluting stents.
- At a median follow-up of 38 months, MACE occurred in 38.9% of patients.
- Among 129 patients needing repeat revascularization, 21.7% required a second TVR-PCI, 5.4% a third, and 1.5% a fourth.
Conclusions:
- Diabetic patients undergoing PCI face frequent adverse events, including a significant rate of repeat revascularization.
- Repeat PCI appears to be a safe and effective strategy for managing recurrent events in this high-risk group.
Aim:
Diabetics with coronary artery disease face a high risk of adverse events following coronary revascularization. However, recurrence rates of after the first revascularization have never been appraised. The aim of this study was to evaluate recurrent events in diabetics undergoing percutaneous coronary intervention (PCI) in the current era.
Methods:
Authors collected baseline and outcome data of consecutive type-2 diabetics treated with PCI (July 2002-December 2005) . End-points of interest were the long-term rates of major adverse cardiac events (MACE: cardiac death, myocardial infarction [MI], percutaneous target vessel revascularization [TVR-PCI], or coronary artery bypass grafting [CABG]), non-TVR PCI, and stent thrombosis.
Results:
A total of 429 diabetics were included, 191 (44%) insulin-dependent, with drug-eluting stents implanted in 232 (54%). After a median of 38 months, events were as follows: MACE in 167 (38.9%) subjects, cardiac death in 38 (8.8%), MI in 42 (9.8%), TVR-PCI in 130 (30.3%), CABG in 11 (2.6%), non-TVR-PCI in 52 (12.1%), and definite stent thrombosis in 9 (2.1%). Among the 129 patients undergoing TVR-PCI as first event, as many as 28 (21.7%) underwent a second TVR-PCI, 7 (5.4%) underwent a third TVR-PCI, and a further 2 (1.5%) underwent a fourth TVR-PCI, whereas CABG was performed in 2 (1.5%) and non-TVR-PCI in 4 (3.1%).
Conclusions:
This work, originally reporting on the risk of recurrent repeat revascularization events among diabetics treated with PCI, showed that adverse events occur frequently in these patients, but can be managed in most cases safely and successfully by means of repeat PCI only.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Diabetic Retinopathy
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care
